At a glance
- Originator Japan Tobacco
- Class
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Disseminated intravascular coagulation; Thrombosis
Most Recent Events
- 09 Aug 2004 Discontinued - Phase-I for Thrombosis (Injection)
- 09 Aug 2004 Discontinued - Phase-I for Thrombosis in Japan (PO)
- 09 Aug 2004 Discontinued - Phase-II for Thrombosis in Japan (Injection)